Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2018 Dec;13(6):533-545.
doi: 10.4103/1735-5362.245965.

Anti-melanogenesis and anti-tyrosinase properties of Pistacia atlantica subsp. mutica extracts on B16F10 murine melanoma cells

Affiliations

Anti-melanogenesis and anti-tyrosinase properties of Pistacia atlantica subsp. mutica extracts on B16F10 murine melanoma cells

Samira Eghbali-Feriz et al. Res Pharm Sci. 2018 Dec.

Abstract

Pistacia atlantica (P. atlantica) subsp. mutica has been used in traditional medicine and is famous for its medicinal properties. The aim of this study was to evaluate the effect of methanol (MeOH), n-hexane, dichloromethane (CH2Cl2), n-butanol (BuOH), ethyl acetate (EtOAc), water extracts and essential oil of P. atlantica subsp. mutica on melanin synthesis and oxidative stress in B16F10 melanoma cell line. The B16F10 cells viability after treatment with increasing concentrations of different extracts of the plant (0.2-200 μg/mL) was measured using resazurin. Essential oil composition was identified by gas-chromatography-mass spectrometry (GC-MS) analysis and inhibitory effect on synthesis of melanin, mushroom tyrosinase activity, cellular tyrosinase, and oxidative stress were evaluated by the colorimetric and fluorometric methods. The data showed extracts at concentrations 0.2-200 μg/mL, did not show significant toxicity on melanoma cells but concentrations of 200 μg/mL of essential oil had cytotoxic effect. Pistacia atlantica subsp. mutica could inhibit the mushroom tyrosinase activity. Also the amount of melanin in B16F10 cells declined. In addition, the ability of P. atlantica subsp. mutica extracts in decreasing the amount of reactive oxygen species in melanoma cells revealed remarkable antioxidant activity. In addition, all concentrations of essential oil had no significant effect in this study. The melanogenesis inhibitory and antioxidant effects of P. atlantica subsp. mutica on B16F10 cells may suggest the potential whitening activity of the plant for using in dermatological skin care products and for prevention of skin aging in cosmetic industry.

Keywords: Anti-tyrosinase; Melanogenesis; P. atlantica subsp. mutica.

PubMed Disclaimer

Figures

Fig. 1
Fig. 1
Cytotoxic effects of Pistacia atlantica subsp.mutica extracts on melanoma cell viability. *P< 0.05, as compared to control.
Fig. 2
Fig. 2
Effect of Pistacia atlantica subsp.mutica extracts on mushroom tyrosinase activity. *P< 0.05, as compared to control.
Fig. 3
Fig. 3
Effect of Pistacia atlantica subsp.mutica extracts on melanin content. *P< 0.05 as compared to control.
Fig. 4
Fig. 4
Effect of Pistacia atlantica subsp.mutica extracts on cellular tyrosinase activity. *P< 0.05 as compared to control.
Fig. 5
Fig. 5
Antioxidant effect of Pistacia atlantica subsp.mutica extracts on cellular reactive oxygen species (ROS) levels.*P< 0.05 as compared to control.
Fig. 6
Fig. 6
Effect of Pistacia atlantica subsp.mutica on cellular tyrosinase protein level. A, Western blotting analysis of tyrosinase and β-actin proteins expression in B16F10 cells; B, the level of tyrosinase in cells normalized to the related β-actin band in comparision with control, *P< 0.05.

Similar articles

Cited by

References

    1. Chung KW, Park YJ, Choi YJ, Park MH, Ha YM, Uehara Y, et al. Evaluation of in vitro and in vivo anti-melanogenic activity of a newly synthesized strong tyrosinase inhibitor (E)-3-(2,4 dihydroxybenzylidene)pyrrolidine-2,5-dione (3-DBP) Biochim Biophys Acta. 2012;1820(7):962–969. - PubMed
    1. Riley PA. Melanogenesis and melanoma. Pigment Cell Res. 2003;16(5):548–552. - PubMed
    1. Abdel-Daim M, Funasaka Y, Komoto M, Nakagawa Y, Yanagita E, Nishigori C. Pharmacogenomics of metabotropic glutamate receptor subtype 1 and in vivo malignant melanoma formation. J Dermatol. 2010;37(7):635–646. - PubMed
    1. Agar N, Young AR. Melanogenesis: a photoprotective response to DNA damage. Mutat Res? 2005;571(1-2):121–132. - PubMed
    1. Hashemi-Shahri SH, Golshan A, Mohajeri SA, Baharara J, Amini E, Salek F, Sahebkar A, Tayarani-Najaran Z. ROS-scavenging and anti-tyrosinase properties of crocetin on B16F10 murine melanoma cells. Anticancer Agents Med Chem. 2017 Epub ahead of print. DOI: 10.2174/1871520618666171213143455. - PubMed